Phase I clinical study of the toll-like receptor 9 agonist MGN1703 in patients with metastatic solid tumours
Titel:
Phase I clinical study of the toll-like receptor 9 agonist MGN1703 in patients with metastatic solid tumours
Auteur:
Weihrauch, Martin R. Richly, Heike von Bergwelt-Baildon, Michael S. Becker, Hans Jiro Schmidt, Manuel Hacker, Ulrich T. Shimabukuro-Vornhagen, Alexander Holtick, Udo Nokay, Bahar Schroff, Matthias Wittig, Burghardt Scheulen, Max E.